Should You Ask Your Doctor for a PSA Test?

Nothing has changed yet. Canada's national advice still recommends against routine screening with the PSA test, and a coalition of cancer organizations has now asked the country's newest health panel to reopen that file. The guideline has never stopped anyone from being tested, though. It says plainly that when a patient raises testing, the doctor should walk through the benefits and harms with them. That conversation is available to you today, whatever Ottawa decides next.

Key takeaways

Canada's formal guidance on testing has not been updated since 2014, when the panel concluded the harms outweighed the benefits at every age band it looked at.

Eleven organizations and researchers signed the letter, among them the Canadian Cancer Society, Movember Canada, The Walnut Foundation and the Canadian Urological Association.

The committee receiving it is new. Ottawa announced the 14-person body in June, and it advises the Public Health Agency of Canada independently.

In the task force's own model of 1,000 men screened over 13 years, 178 get a raised result with no cancer found, 102 are diagnosed, and 1 death is avoided.

The Canadian Urological Association suggests starting at 50 for most men and 45 for men at higher risk, always as a shared decision.

In Ontario the blood test runs about $40 when you pay yourself, because provincial coverage generally applies only when cancer is already suspected or diagnosed.

What Do the PSA Test Guidelines in Canada Say Right Now?

The short answer is that the PSA test guidelines in Canada recommend against screening, and have said so since 2014. PSA stands for prostate-specific antigen, a protein made by the prostate gland that shows up in a blood sample. The PSA test is nothing more than that blood draw, and the appeal of measuring the protein is obvious, since a raised level can be an early warning in a man who feels completely fine. Blood numbers earn their keep by surfacing what you cannot feel, the same reason one ordinary blood test settles the always-tired-and-cold question for people who spent years assuming it was just age.

The 2014 recommendations sit on the task force's own guideline page, and they are worth reading in full because the wording is more careful than the headlines suggest. For men under 55, the recommendation against screening is strong, based on low-quality evidence. For men aged 55 to 69, it is weak, based on moderate quality evidence. For men 70 and over, it is strong again. A weak recommendation in guideline language is close to an invitation to discuss it, not a locked door.

Who Is Asking Ottawa to Review the PSA Test Advice?

A coalition of eleven cancer organizations, advocates and researchers signed a letter asking the National Advisory Committee on Preventative Health Services to review the PSA test advice that has stood untouched for twelve years, as reported by The Globe and Mail. Their argument is that the guideline no longer matches how doctors are actually practising, and that updating it would improve detection and prevention.

Timing matters here. The committee is brand new, a 14-person body Ottawa announced in June to build guidelines for primary care teams, advising the Public Health Agency of Canada independently. Its predecessor was shut down more than a year earlier after heavy criticism for declining to lower the recommended breast screening age from 50 to 40, so this panel arrives with a great deal of attention on it.

The Walnut Foundation is one signatory, and its involvement points at the equity question underneath the science. The Toronto charity supports Black men through diagnosis and recovery and runs free testing clinics, on the basis that Black men in Canada are far more likely to be diagnosed and more than twice as likely to die of the disease. A blanket recommendation lands differently on a group that starts at higher risk.

How Accurate Is a PSA Test Across 1,000 Men?

If you want a straight answer to how accurate is a PSA test, the task force published one, and it is unusually honest. Its thousand-person breakdown follows 1,000 men aged 55 to 69 screened over 13 years, and the numbers explain both sides of this argument better than any position statement.

720 men get a normal result and go home.

178 get a raised result with no cancer found on follow-up. Four end up in hospital with bleeding or infection from the biopsy it triggered.

102 are diagnosed. Of those, 33 have a cancer that would never have caused illness or death, yet almost all will be treated anyway, because nobody can reliably tell in advance which ones stay harmless.

5 men die of the disease despite being screened. One man escapes death because he was screened.

Set against no screening at all, the death rate moves from 6 in 1,000 to 5 in 1,000, and preventing that single death means 27 additional men are diagnosed with cancer they would otherwise never have known about. Whether that trade is worth making is a values question as much as a medical one, which is why the newer argument is about who decides rather than what the blanket rule says.

Which PSA Test Harms Worried the Panel in 2014?

The PSA test harms that shaped the 2014 decision were never about the blood draw. They were about everything a raised number sets in motion. Overdiagnosis sits at the top of that list, meaning cancers found that would never have progressed far enough to cause symptoms or shorten a life. Finding them is not free, because most men understandably choose treatment once the word cancer has been said out loud. For every 1,000 men treated, the task force counted 127 to 442 with long-term erectile dysfunction, up to 178 with urinary incontinence, and 4 to 5 who die of complications of the treatment itself.

What has shifted since is the pathway that follows a raised result. Screening is moving away from blood results and physical examination alone, toward targeted imaging before any biopsy and newer blood tests that sort higher risk from lower, part of the same shift that produced the liquid biopsy now being tested for cancer recurrence. A 2025 review argued Canada's current approach may amplify harms and disparities among the groups already at highest risk, which is a different criticism from saying the old numbers were wrong.

What Should You Expect If You Ask for a PSA Test?

Practically, when you ask for a PSA test, you are asking for a standard blood draw, with the result reported as a number in nanograms per millilitre. No fasting, no preparation, no imaging at this stage. The decision sits before the needle rather than after it.

Cost surprises people. In Ontario, the test runs about $40 when you pay yourself, because provincial coverage generally applies only when cancer is suspected or already being followed. Rules differ by province, so ask at the appointment rather than at the lab counter.

If the number comes back raised, expect a repeat test first, since a single reading can be pushed up by infection, recent cycling or an enlarged gland that has nothing to do with cancer. After that, the pathway may involve imaging, where Ontario's ultrasound backlog is a story of its own, and possibly a referral, which is where Canadian timelines get uneven. Our reporting on how long the wait to see a specialist really runs is a useful reality check on the calendar after the blood work, and going in with your questions already written down is the cheapest way to protect a short appointment. Our guide to preparing for a doctor's appointment covers that one page.

When Should You Bring Up a PSA Test With Your Doctor?

There is no single answer to when you should bring up a PSA test, but there is a workable starting point. The Canadian Urological Association suggests age 50 for most men and 45 for men at increased risk, framing it as a shared decision after the benefits and harms have been discussed. Increased risk usually means a father or brother who was diagnosed, or Black ancestry, or both. The task force and the urologists disagree about the default and agree completely about the conversation.

So bring it up the way you would bring up any symptom you have been sitting on. Men are famously slow to do this, the same instinct behind ignoring a cough that will not clear after 40, and the fix is identical. Say it out loud, early, to someone who can act on it.

Write down your family history first, specifically any father, brother or uncle diagnosed and the age at which it happened. That single detail changes the advice more than anything else you can bring.

Book it as its own visit rather than tacking it onto something else, since a shared decision needs more than the last two minutes. With no family doctor, a walk-in clinic can order the blood work and start the file.

Ask two direct questions. What does my own risk picture look like, and what happens next if the number comes back raised.

Check what your province covers before you leave the room, so a $40 surprise does not become the reason you skip it.

Agree on a plan and write it down, including whether you are testing now, waiting, or revisiting at a set age. A decision you can repeat back is one you actually made.

What Else Do People Ask About the PSA Test?

What does the blood test actually measure?

It measures prostate-specific antigen, a protein made by the prostate gland that circulates in small amounts in the blood. A higher level can signal cancer, but it can also reflect an enlarged gland, a recent infection, or even a long bike ride. The number is a prompt for a conversation, never a diagnosis on its own.

Does a raised result always mean something is wrong?

Usually not. In the Canadian task force model of 1,000 men screened, 178 have a raised result with no cancer found on follow-up, against 102 who are diagnosed. That is why a single high reading is normally repeated before anyone moves to imaging or biopsy, and why the follow-up pathway matters as much as the test.

At what age do doctors usually suggest starting?

It depends who you ask. The national guideline recommends against routine screening at every age. The Canadian Urological Association suggests offering the PSA test from age 50 for most men, and from 45 for men at increased risk, always after a discussion of benefits and harms rather than as an automatic order.

Are Black men at higher risk?

Yes. Black men of African or Caribbean ancestry are substantially more likely to be diagnosed and more than twice as likely to die of the disease, according to The Walnut Foundation, which runs free testing clinics in the Greater Toronto Area. Family history carries similar weight, and both are reasons to start the conversation earlier.

Is the blood work covered by provincial health plans?

It varies by province. In Ontario, it is covered when cancer is suspected, already diagnosed, or being followed after treatment, and costs roughly $40 otherwise. Some provinces cover it as a screening tool, and others do not, so confirm at the appointment rather than assuming the answer either way.

Your next step

If you have been meaning to have this conversation and do not have a family doctor to have it with, start where the door is open. Medimap shows you walk-in clinics near you with current wait times, and if you are trying to get properly attached to someone who will follow this over years rather than one visit, compare family practices taking patients instead. You can also search by symptom or clinic name if you are not sure which door you need. For more plain explainers on tests, waits, and what to ask, the Medimap Health Hub is the place to start.

Disclaimer. This article is general information, not medical advice, and it cannot tell you whether testing is right for you. For a medical emergency call 911. For anything non-urgent, speak with a doctor or nurse practitioner who knows your history.